☆ 4.7 Article

Development of receptor binding domain-based double-antigen sandwich lateral flow immunoassay for the detection and evaluation of SARS-CoV-2 neutralizing antibody in clinical sera samples compared with the conventional virus neutralization test

TALANTA (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

A Lateral Flow Immunoassay Coupled with a Spectrum-Based Reader for SARS-CoV-2 Neutralizing Antibody Detection

Rui-Lin Huang et al.

Summary: The study explores the use of lateral flow immunoassays coupled with a spectrum-based reader to detect the presence of neutralizing antibodies in both COVID-19-infected and vaccinated patients. The results indicate that this approach has significant diagnostic value and shows a high correlation with conventional enzyme-linked immunosorbent assay results.

VACCINES (2022)

添加到收藏夹

Article Biophysics

Dual-detection fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike RBD-ACE2 blocking neutralizing antibody

Xuejun Duan et al.

Summary: This article introduces a dual-detection fluorescent immunochromatographic assay (DFIA) for rapid quantitative detection of neutralizing antibodies against SARS-CoV-2. The assay uses a self-calibration process and demonstrates improved precision, sensitivity, and a wider dynamic linear range.

BIOSENSORS & BIOELECTRONICS (2022)

添加到收藏夹

Article Infectious Diseases

Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals

Farah M. Shurrab et al.

Summary: The performance of the fluorescence LFIA Finecare (TM) 2019-nCoV S-RBD test was evaluated and found to have high sensitivity and specificity, with consistent results compared to reference assays. This test can be used for quantitative measurement of SARS-CoV-2 antibodies and serves as an alternative method to assess antibody response after infection or vaccination in small or non-laboratory settings.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Infectious Diseases

Development of a smartphone-based quantum dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies

Jinfeng Li et al.

Summary: A quantum dot lateral flow immunoassay strip (QD-LFIA) for smartphones was designed to detect specific IgG or neutralizing antibodies in SARS-CoV-2. The results showed high sensitivity and specificity in detecting antibodies in recovered patients and vaccinated individuals, with no cross-reaction observed.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Biophysics

Artificial intelligence-assisted colorimetric lateral flow immunoassay for sensitive and quantitative detection of COVID-19 neutralizing antibody

Haoyang Tong et al.

Summary: An AI-assisted PDA-based LFIA platform for quantifying neutralizing antibodies produced from COVID-19 vaccinations was developed, showing sensitivity and accuracy in large-scale evaluation of vaccine effectiveness.

BIOSENSORS & BIOELECTRONICS (2022)

添加到收藏夹

Article Infectious Diseases

A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization

David Peterhoff et al.

Summary: The study developed a specific and sensitive enzyme linked immunosorbent assay (ELISA) for detection of anti-SARS-CoV-2 antibody levels. The ELISA showed high specificity and strong correlation in detecting SARS-CoV-2 antibodies, and was able to generate robust antibody levels 10 days after symptom onset.

INFECTION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

COVID-19-neutralizing antibodies predict disease severity and survival

Wilfredo F. Garcia-Beltran et al.

Summary: Severe cases of COVID-19 show increased inflammatory markers, lymphopenia, pro-inflammatory cytokines, and high antibody levels. High neutralization potency is a predictor of survival. Patient sera can neutralize different strains, indicating cross-protection from reinfection.

CELL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

Alicia T. Widge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

添加到收藏夹

Review Virology

Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies

Maxwell T. Finkelstein et al.

Summary: This review summarizes recent studies focusing on the development of monoclonal antibodies and vaccines against SARS-CoV-2. By studying the structural details of the virus, important information for the treatment and prevention of COVID-19 can be obtained.

VIRUSES-BASEL (2021)

添加到收藏夹

Article Virology

Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2

Douglas F. Lake et al.

Summary: A novel neutralizing antibody test was developed to measure levels of neutralizing antibodies in COVID-19 patients using blood samples, and it was tested in COVID-19 vaccine recipients, showing a significant increase in neutralizing antibody levels after the second vaccine dose, especially in non-infected individuals.

JOURNAL OF CLINICAL VIROLOGY (2021)

添加到收藏夹

Article Allergy

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

Carlo Cervia et al.

Summary: The study found that severe COVID-19 patients experienced a significant increase in SARS-CoV-2 antibody titers after symptom onset, especially with high IgA titers, while mild cases may exhibit transient production of SARS-CoV-2-specific antibodies. Interestingly, some healthcare workers with negative serum antibody titers showed SARS-CoV-2-specific IgA in mucosal fluids with virus-neutralizing capacity in some cases.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Matthew McCallum et al.

Summary: The study identifies 41 human monoclonal antibodies that recognize the N-terminal domain of the SARS-CoV-2 spike protein and exhibit strong neutralizing activity. These antibodies inhibit cell-to-cell fusion, activate effector functions, and protect animals from virus challenge, highlighting the importance of NTD-specific neutralizing antibodies for protective immunity and vaccine development. Several SARS-CoV-2 variants with mutations in the NTD supersite suggest ongoing selective pressure on the virus.

CELL (2021)

添加到收藏夹

Article Medical Laboratory Technology

Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies

Nathan Cook et al.

Summary: The study aimed to detect antibodies to different SARS-CoV-2 antigens, analyzing the performance of the BioRad SARS-CoV-2 IgG multiplex assay in terms of diagnostic accuracy, differentiation of vaccination and natural disease, and retrospective exposure determination. Results showed that the assay is comparable to existing methods, achieving 100% sensitivity when all markers are included, with practical implications for research and infection prevention strategies.

CLINICAL BIOCHEMISTRY (2021)

添加到收藏夹

Article Immunology

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants

Saya Moriyama et al.

Summary: Antibody titers against SARS-CoV-2 decrease over time, but the neutralizing potency against the original virus and variants actually improves with time. Late convalescent antibodies show increased neutralization potency against variants, suggesting that antibody response maturation enhances cross-neutralizing ability against circulating variants. This indicates that declining antibody titers may not necessarily mean declining protection.

IMMUNITY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Qihui Wang et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Bin Ju et al.

NATURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Luca Piccoli et al.

CELL (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction

Chee Wah Tan et al.

NATURE BIOTECHNOLOGY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

A simple protein-based surrogate neutralization assay for SARS-CoV-2

Kento T. Abe et al.

JCI INSIGHT (2020)

添加到收藏夹

Review Immunology

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models

David S. Khoury et al.

NATURE REVIEWS IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells

Hua-Long Xiong et al.

EMERGING MICROBES & INFECTIONS (2020)

添加到收藏夹

Article Immunology

Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients

Baweleta Isho et al.

SCIENCE IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

Jianhui Nie et al.

EMERGING MICROBES & INFECTIONS (2020)

添加到收藏夹

Article Chemistry, Organic

Synthesis and properties of nanospheres copolymerised with luminescent europium(III) chelates

H Hakala et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2006)

添加到收藏夹

Article Chemistry, Analytical

Preparation and a time-resolved fluoroimmunoassay application of new europium fluorescent nanoparticles

XD Hai et al.

ANALYTICAL SCIENCES (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.